Hasil Pencarian - Francisco Cruzalegui
- Menampilkan 1 - 4 hasil dari 4
-
1
315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody oleh Aurélien Marabelle, Carlos Gomez-Roca, Pierre Ferre, Eric Chetaille, Aurelie Petain, Celine Thuilliez, Isabelle Vandenberghe, Francisco Cruzalegui, Asmaa Boudribila, Mariya Pavlyuk
Diterbitkan 2020-11-01Artikel -
2
Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells. oleh Sylvie Maubant, Bruno Tesson, Virginie Maire, Mengliang Ye, Guillem Rigaill, David Gentien, Francisco Cruzalegui, Gordon C Tucker, Sergio Roman-Roman, Thierry Dubois
Diterbitkan 2015-01-01
Artikel -
3
Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. oleh Florence Sancier, Aurélie Dumont, Audrey Sirvent, Ludmilla Paquay de Plater, Thomas Edmonds, Géraldine David, Michel Jan, Catherine de Montrion, Francis Cogé, Stéphane Léonce, Michael Burbridge, Alain Bruno, Jean A Boutin, Brian Lockhart, Serge Roche, Francisco Cruzalegui
Diterbitkan 2011-02-01
Artikel -
4
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer. oleh Virginie Maire, Céline Baldeyron, Marion Richardson, Bruno Tesson, Anne Vincent-Salomon, Eléonore Gravier, Bérengère Marty-Prouvost, Leanne De Koning, Guillem Rigaill, Aurélie Dumont, David Gentien, Emmanuel Barillot, Sergio Roman-Roman, Stéphane Depil, Francisco Cruzalegui, Alain Pierré, Gordon C Tucker, Thierry Dubois
Diterbitkan 2013-01-01
Artikel